Category Archives: Competition
Remedies for a Healthy Patient II
Like the links in an apparently never-ending chain, the FCA’s Asset Management Market Study has now produced a Policy Statement (PS 18/8) (PS18/8: Implementing asset management market study remedies and changes to our Handbook – feedback to CP17/18 and final …
Click here to read the rest of this entry
Best Execution – Again
It would not be entirely fair to accuse the Regulator of banging-on endlessly about best execution. Until the publication of the Thematic Review in 2014 (TR 14/13), it had said nothing about it for years. And there was precious little …
Click here to read the rest of this entry
Tagged in: Best Execution, competition, ESMA, FCA visit, MiFID
Looking Forward To It
Every New Year offers much to look forward to and 2017 is no exception. Some may look forward to it with relish, some with reservations and some with trepidation. For all, this time, it should be an exciting ride. The …
Click here to read the rest of this entry
Tagged in: asset management market study, BREXIT, competition, Equivalence, EU, FCA, MiFID, Passport, Research Payment Account, RPA